Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
66%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
OZEM
19
HOLDINGS
83%
ALSO IN THNR
THNR
18
HOLDINGS
83%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 19.3% | 15.6% | 15.6% | |
| NOVO-NORDISK A/S-SPONS ADR | 14.4% | 10.3% | 10.3% | |
| ROCHE HOLDING LTD | 5.7% | 5.4% | 5.4% | |
| CHUGAI PHARMACEUTICAL CO LTD | 5.3% | 7.3% | 5.3% | |
| AMGEN INC | 3.9% | 7.3% | 3.9% | |
OZEM Overweight Relative to THNR
| VIKING THERAPEUTICS, INC. | 6.4% | |
| NOVO-NORDISK A/S-SPONS ADR | 4.1% | |
| ELI LILLY & CO | 3.8% | |
| ZEALAND PHARMA A/S | 2.4% | |
| HANMI PHARM CO LTD | 2.0% | |
| RHYTHM PHARMACEUTICALS, INC. | 1.9% | |
| GILEAD SCIENCES INC | 1.8% | |
| SCHOLAR ROCK HOLDING CORP. | 0.9% | |
| THE UNITED LABORATORIES INTE | 0.7% | |
| ROCHE HOLDING LTD | 0.3% |
OZEM Underweight Relative to THNR
| MERCK & CO. INC. | -5.5% | |
| ABBVIE INC | -4.8% | |
| REGENERON PHARMACEUTICALS | -4.4% | |
| HIMS & HERS HEALTH, INC. CLASS A | -3.5% | |
| AMGEN INC | -3.3% | |
| SHIONOGI & CO LTD | -3.1% | |
| CHINA PHARMACEUTICAL GROUP | -2.2% | |
| CHUGAI PHARMACEUTICAL CO LTD | -2.0% | |
| ASTRAZENECA PLC-SPONS ADR | -1.3% | |
| PFIZER INC | -1.0% |